Cargando…

The cancer degradome : proteases and cancer biology /

This book will aim to cover recent knowledge of the composition of the Degradome, how it can be studied using modern approaches such as transcriptomics and mass spectrometry; how gene knockout mice have improved our knowledge of the roles of proteases in cancer; how their activity can be imaged both...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Edwards, Dylan R.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer, ©2008.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn288472766
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 081217s2008 nyuaf ob 001 0 eng d
040 |a GW5XE  |b eng  |e pn  |c GW5XE  |d OCLCQ  |d MHW  |d N$T  |d IDEBK  |d E7B  |d OCLCQ  |d EBLCP  |d OCLCQ  |d A7U  |d OCLCQ  |d OCLCF  |d BEDGE  |d OCLCQ  |d SLY  |d NLGGC  |d CDX  |d UBC  |d COO  |d YDXCP  |d DEBSZ  |d OCLCQ  |d TXI  |d OCLCQ  |d AZK  |d LOA  |d COCUF  |d Z5A  |d PIFAG  |d OTZ  |d ZCU  |d OCLCQ  |d MERUC  |d ESU  |d OCLCQ  |d VT2  |d STF  |d OCLCO  |d MERER  |d OCLCO  |d U3W  |d WRM  |d OCLCQ  |d CEF  |d NRAMU  |d OCLCO  |d INT  |d AU@  |d OCLCO  |d OCLCQ  |d OCLCO  |d LHU  |d WYU  |d OCLCO  |d YOU  |d TKN  |d OCLCQ  |d NZHMA  |d DKC  |d OCLCO  |d OCLCQ  |d CNTRU  |d OCLCO  |d UX1  |d AUD  |d OCLCO  |d OCLCQ  |d HS0  |d ZHM  |d OCLCQ  |d UKBTH  |d OCLCA  |d SNU  |d UK7LJ  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 276222138  |a 300047747  |a 317310115  |a 646764823  |a 698466334  |a 756437853  |a 815691366  |a 823118369  |a 824149493  |a 880101179  |a 961548573  |a 962604794  |a 974576475  |a 974613334  |a 988829538  |a 1018012519  |a 1040546948  |a 1041778119  |a 1053411093  |a 1061400424  |a 1066632928  |a 1087298529  |a 1096480350  |a 1097316021  |a 1100557231  |a 1101710980  |a 1109200948  |a 1110734074  |a 1112862578  |a 1112922675  |a 1154885210  |a 1155973953  |a 1159609965  |a 1162744068  |a 1244441736  |a 1244443688 
020 |a 9780387690575 
020 |a 0387690573 
020 |a 128179189X 
020 |a 9781281791894 
020 |a 9786611791896 
020 |a 6611791892 
020 |z 0387690565 
020 |z 9780387690568 
024 7 |a 10.1007/978-0-387-69057-5.  |2 doi 
029 1 |a AU@  |b 000048699380 
029 1 |a AU@  |b 000058156549 
029 1 |a AU@  |b 000060528577 
029 1 |a CDX  |b 9044205 
029 1 |a DEBBG  |b BV044130750 
029 1 |a DEBSZ  |b 43066740X 
029 1 |a NZ1  |b 12808242 
035 |a (OCoLC)288472766  |z (OCoLC)276222138  |z (OCoLC)300047747  |z (OCoLC)317310115  |z (OCoLC)646764823  |z (OCoLC)698466334  |z (OCoLC)756437853  |z (OCoLC)815691366  |z (OCoLC)823118369  |z (OCoLC)824149493  |z (OCoLC)880101179  |z (OCoLC)961548573  |z (OCoLC)962604794  |z (OCoLC)974576475  |z (OCoLC)974613334  |z (OCoLC)988829538  |z (OCoLC)1018012519  |z (OCoLC)1040546948  |z (OCoLC)1041778119  |z (OCoLC)1053411093  |z (OCoLC)1061400424  |z (OCoLC)1066632928  |z (OCoLC)1087298529  |z (OCoLC)1096480350  |z (OCoLC)1097316021  |z (OCoLC)1100557231  |z (OCoLC)1101710980  |z (OCoLC)1109200948  |z (OCoLC)1110734074  |z (OCoLC)1112862578  |z (OCoLC)1112922675  |z (OCoLC)1154885210  |z (OCoLC)1155973953  |z (OCoLC)1159609965  |z (OCoLC)1162744068  |z (OCoLC)1244441736  |z (OCoLC)1244443688 
037 |a 978-0-387-69056-8  |b Springer  |n http://www.springerlink.com 
050 4 |a QP609.P78  |b C36 2008eb 
060 4 |a QU 136  |b C215 2008 
072 7 |a SCI  |x 007000  |2 bisacsh 
072 7 |a MJCL.  |2 bicssc 
082 0 4 |a 572/.76  |2 22 
084 |a R730. 231  |2 clc 
049 |a UAMI 
245 0 4 |a The cancer degradome :  |b proteases and cancer biology /  |c Dylan Edwards [and others], editors. 
246 3 0 |a Proteases and cancer biology 
260 |a New York, NY :  |b Springer,  |c ©2008. 
300 |a 1 online resource (xxiii, 926 pages, 32 unnumbered pages of plates) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
504 |a Includes bibliographical references and index. 
520 |a This book will aim to cover recent knowledge of the composition of the Degradome, how it can be studied using modern approaches such as transcriptomics and mass spectrometry; how gene knockout mice have improved our knowledge of the roles of proteases in cancer; how their activity can be imaged both in vitro and in vivo; the links that have emerged between proteolysis and cell signalling; how the degradome can be a useful source of diagnostic and prognostic markers; and finally new approaches to targeting proteolysis for therapy. 
588 0 |a Print version record. 
505 0 |a The Degradome and Its Analysis -- Protease Genomics and the Cancer Degradome -- The CLIP-CHIP™: A Focused Oligonucleotide Microarray Platform for Transcriptome Analysis of the Complete Human and Murine Cancer Degradomes -- The Hu/Mu ProtIn Chip: A Custom Dual-Species Oligonucleotide Microarray for Profiling Degradome Gene Expression in Tumors and Their Microenvironment -- Quantitative Real-Time PCR Analysis of Degradome Gene Expression -- Identification of Protease Substrates by Mass Spectrometry Approaches-1 -- Identification of Protease Substrates by Mass Spectrometry Approaches-2 -- Activity-Based Imaging and Biochemical Profiling Tools for Analysis of the Cancer Degradome -- Images of Cleavage: Tumor Proteases in Action -- Insights into Protease Function -- Proteolytic Pathways: Intersecting Cascades in Cancer Development -- Physiological Functions of Plasminogen Activation: Effects of Gene Deficiencies in Humans and Mice -- The Plasminogen Activation System in Tissue Remodeling and Cancer Invasion -- The Urokinase Plasminogen Activator Receptor as a Target for Cancer Therapy -- The Endocytic Collagen Receptor, uPARAP/Endo180, in Cancer Invasion and Tissue Remodeling -- Physiological and Pathological Functions of Type II Transmembrane Serine Proteases: Lessons from Transgenic Mouse Models and Human Disease-Associated Mutations -- Roles of Cysteine Proteases in Tumor Progression: Analysis of Cysteine Cathepsin Knockout Mice in Cancer Models -- In Vitro and In Vivo Models of Angiogenesis to Dissect MMP Functions -- The Surface Transplantation Model to Study the Tumor-Host Interface -- Unravelling the Roles of Proteinases in Cell Migration In Vitro and In Vivo -- New Insights into MMP function in Adipogenesis -- TIMPs: Extracellular Modifiers in Cancer Development -- The Interface Between Proteolysis and Cell Signalling -- Invadopodia: Interface for Invasion -- uPAR and Proteases in Mobilization of Hematopoietic Stem Cells -- The Urokinase Receptor and Integrins Constitute a Cell Migration Signalosome -- Measuring uPAR Dynamics in Live Cells -- Janus-Faced Effects of Broad-Spectrum and Specific MMP Inhibition on Metastasis -- Cytokine Substrates: MMP Regulation of Inflammatory Signaling Molecules -- Matrix Metalloproteinases as Key Regulators of Tumor-Bone Interaction -- The Degradome as Source of Cancer Diagnostic and Markers -- The Plasminogen Activation System as a Source of Prognostic Markers in Cancer -- Cysteine Cathepsins and Cystatins as Cancer Biomarkers -- Novel Degradome Markers in Breast Cancer -- Meta-Analysis of Gene Expression Microarray Data: Degradome Genes in Healthy and Cancer Tissues -- Degradome Gene Polymorphisms -- TIMP-1 as a Prognostic Marker in Colorectal Cancer -- Novel Therapeutic Strategies -- Structure and Inhibition of the Urokinase-Type Plasminogen Activator Receptor -- Engineered Antagonists of uPA and PAI-1 -- MMP Inhibitor Clinical Trials -- The Past, Present, and Future -- Tailoring TIMPs for Selective Metalloproteinase Inhibition -- Third-Generation MMP Inhibitors: Recent Advances in the Development of Highly Selective Inhibitors -- Protease-Activated Delivery and Imaging Systems -- Development of Tumour-Selective and Endoprotease-Activated Anticancer Therapeutics -- Targeting Degradome Genes via Engineered Viral Vectors. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Proteolytic enzymes. 
650 0 |a Cancer  |x Molecular aspects. 
650 1 2 |a Peptide Hydrolases 
650 2 2 |a Neoplasm Invasiveness  |x enzymology 
650 6 |a Enzymes protéolytiques. 
650 6 |a Cancer  |x Aspect moléculaire. 
650 7 |a SCIENCE  |x Life Sciences  |x Biochemistry.  |2 bisacsh 
650 0 7 |a Cancer  |x Molecular aspects.  |2 cct 
650 0 7 |a Peptide hydrolases.  |2 cct 
650 0 7 |a Neoplasm Invasiveness  |x enzymology.  |2 cct 
650 0 7 |a Proteolytic enzymes.  |2 cct 
650 7 |a Biomédecine.  |2 eclas 
650 7 |a Sciences de la vie.  |2 eclas 
650 7 |a Cancer  |x Molecular aspects  |2 fast 
650 7 |a Proteolytic enzymes  |2 fast 
700 1 |a Edwards, Dylan R. 
758 |i has work:  |a The cancer degradome (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGDm4fmmX67XvjqxMRJyHP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Cancer degradome.  |d New York, NY : Springer, ©2008  |z 9780387690568  |z 0387690565  |w (OCoLC)227032670 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=364191  |z Texto completo 
938 |a Coutts Information Services  |b COUT  |n 9044205 
938 |a EBL - Ebook Library  |b EBLB  |n EBL364191 
938 |a ebrary  |b EBRY  |n ebr10252325 
938 |a EBSCOhost  |b EBSC  |n 245158 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 179189 
938 |a YBP Library Services  |b YANK  |n 2892729 
994 |a 92  |b IZTAP